Zinzino AB

Zinzino names three-member nomination committee for 2027 AGM

GOTHENBURG -- November 16, 2026 -- Zinzino AB (publ) has appointed the nomination committee for its Annual General Meeting on May 25, 2027. Two of the three seats go to representatives of shareholders Saele Invest AS and Cashflow Holding ApS.

Magnus Götenfelt sits on the committee for Saele Invest AS, and Cecilia Halldner sits for Cashflow Holding ApS. Hans Jacobsson, Chairman of the Board, holds the third seat. Shareholder appointees therefore make up two-thirds of the committee, and the Chairman is the only board member on it.

The committee was formed under the Nomination Committee Charter adopted at the Annual General Meeting 2026. The company dated the appointment November 10, 2026. The meeting will take place in Gothenburg, 190 days after November 16, 2026 by our calculation.

Zinzino Group Revenue Rises 15% to SEK 282.2M in August 2026

Gothenburg – – September 08, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Faun Pharma external sales drop to SEK 1.3 million from SEK 3.4 million

Faun Pharma's external sales fell to SEK 1.3 million in August 2026, down from SEK 3.4 million a year earlier, a decline that partially offset the stronger performance of Zinzino's sales markets and reduced the group's overall growth rate to 15% from the 16% posted by the sales markets alone.